Ledger.Open graph →
SEC Form D · filed April 22, 2019

Poseida Therapeutics, Inc

Offering
$150.0M
Sold
$142.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

John J. Schmid · San Diego, CADirectorMarcea B. Lloyd · San Diego, CADirectorEric Ostertag · LA JOLLA, CAExec · DirectorMatthew Spear · San Diego, CAExecNoah J. Berkowitz · San Diego, CADirectorDavid Hirsch · Pittsburgh, PADirectorCatherine J. Mackey · Northbrook, ILDirectorSean J. Murphy · San Diego, CADirectorMark Gergen · San Diego, CAExec · DirectorJohn J. Schmid · San Diego, CADirectorNoah J. Berkowitz · San Diego, CADirectorMarcea B. Lloyd · San Diego, CADirectorEric Ostertag · LA JOLLA, CAExec · DirectorDavid Hirsch · New York, NYDirectorCatherine J. Mackey · Northbrook, ILDirectorSean J. Murphy · San Diego, CADirectorMark Gergen · San Diego, CAExec · DirectorMatthew Spear · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗